Alzheimer’s discovery could bring early diagnosis, treatment closer.
It is not often a reason to be excited when a new paper on biochemistry is published but; From McGill University a offers new hope for the early diagnosis and treatment of Alzheimer’s disease. In a study published in the Journal of Biological Chemistry on May 15, Dr. Hemant Paudel, his PhD student Dong Han and postdoctoral fellows Hamid Qureshi and Yifan Lu, report that the addition of a single phosphate to an amino acid in a key brain protein is a principal cause of Alzheimer’s. Identifying this phosphate, one of up to two-dozen such molecules, could make earlier diagnosis of Alzheimer’s possible and might, in the longer term, lead to the development of drugs to block its onset. “The impact of this study is twofold,” said Paudel, “We can now do brain imaging at the earliest stages of the disease. We don’t have to look for many different tau phosphates, just this single phosphate. The possibility of early diagnosis now exists. “Second, the enzyme which puts this phosphate on the tau can be targeted by drugs, so therapies can be developed. This discovery gives us, for the first time, a clear direction towards the early diagnosis and treatment of Alzheimer’s.”
